Impact of the Cell Cycle Progression Test on Physician and Patient Treatment Selection for Localized Prostate Cancer.

Abstract

PURPOSE The cell cycle progression test is a validated molecular assay that assesses prostate cancer specific disease progression and mortality risk when combined with clinicopathological parameters. We present the results from PROCEDE-1000, a large, prospective registry designed to evaluate the impact of the cell cycle progression test on shared treatment… (More)
DOI: 10.1016/j.juro.2015.09.072

Topics

3 Figures and Tables

Cite this paper

@article{Shore2016ImpactOT, title={Impact of the Cell Cycle Progression Test on Physician and Patient Treatment Selection for Localized Prostate Cancer.}, author={Neal D. Shore and Naveen Kella and Brian Moran and Judd Boczko and Fernando J. Bianco and E. David Crawford and Thaylon Davis and Kirstin M. Roundy and Kristen Rushton and Charles E Grier and Rajesh R Kaldate and Michael K. Brawer and Mark L. Gonzalgo}, journal={The Journal of urology}, year={2016}, volume={195 3}, pages={612-8} }